Browsing by Author 유대현

Jump to:
All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 30 of 90

Issue DateTitleAuthor(s)
2015-10Analysis of clinical trials of biosimilar infliximab (CT-P13) and comparison against historical clinical studies with the infliximab reference medicinal product유대현
2014-12Analysis of predictors influencing indeterminate whole-blood interferon-gamma release assay results in patients with rheumatic diseases유대현
2016-06Association-heterogeneity mapping identifies an Asian-specific association of the GTF2I locus with rheumatoid arthritis유대현
2015-10Baseline Characteristics of the Korean Registry of Pulmonary Arterial Hypertension유대현
2016-04Bone Scintigraphy in the Diagnosis of Rheumatoid Arthritis: Is There Additional Value of Bone Scintigraphy with Blood Pool Phase over Conventional Bone Scintigraphy?유대현
2017-06Characteristics and outcomes of rheumatoid arthritis patients who started biosimilar infliximab유대현
2013-06CHARACTERISTICS, OUTCOMES, AND PREDICTORS OF COMPLEMENTARY AND ALTERNATIVE MEDICINE USE IN PATIENTS WITH RHEUMATOID ARTHRITIS유대현
2017-06Clinical characteristics and outcomes of diffuse alveolar hemorrhage in patients with systemic lupus erythematosus유대현
2013-12A Clinical Trial and Extension Study of Infliximab in Korean Patients with Active Rheumatoid Arthritis despite Methotrexate Treatment유대현
2016-01Comparable long-term efficacy, as assessed by patient-reported outcomes, safety and pharmacokinetics, of CT-P13 and reference infliximab in patients with ankylosing spondylitis: 54-week results from the randomized, parallel-group PLANETAS study유대현
2017-11Comparative effectiveness of the biosimilar CT-P13유대현
2017-06Comparative effectiveness of treatment options after conventional DMARDs failure in rheumatoid arthritis유대현
2014-07A comparison of incidence and risk factors for serious adverse events in rheumatoid arthritis patients with etanercept or adalimumab in Korea and Japan유대현
2015-10Comparison of the pharmacokinetics and safety of three formulations of infliximab (CT-P13, EU-approved reference infliximab and the US-licensed reference infliximab) in healthy subjects: a randomized, double-blind, three-arm, parallel-group, single-dose, Phase I study유대현
2017-07CT-P13 in the treatment of rheumatoid arthritis유대현
2012-08Do Patients with Elderly-Onset Rheumatoid Arthritis Have Severe Functional Disability?유대현
2016-08Drug retention and safety of TNF inhibitors in elderly patients with rheumatoid arthritis유대현
2013-06EFFECTS OF EARLY DIAGNOSIS ON DISEASE ACTIVITY AND FUNCTIONAL DISABILITY IN RHEUMATOID ARTHRITIS유대현
2017-02Efficacy and safety of CT-P13 (biosimilar infliximab) in patients with rheumatoid arthritis: comparison between switching from reference infliximab to CT-P13 and continuing CT-P13 in the PLANETRA extension study유대현
2013-10Efficacy and Safety of CT-P13 (Infliximab Biosimilar) over Two Years in Patients with Ankylosing Spondylitis: Comparison Between Continuing with CT-P13 and Switching from Infliximab to CT-P13유대현
2019-02Efficacy and safety of mycophenolate mofetil and tacrolimus combination therapy in patients with lupus nephritis: a nationwide multicentre study유대현
2017-08Efficacy and Safety of Switching from Innovator Rituximab to Biosimilar CT-P10 Compared with Continued Treatment with CT-P10: Results of a 56-Week Open-Label Study in Patients with Rheumatoid Arthritis유대현
2017-02Efficacy and safety of switching from reference infliximab to CT-P13 compared with maintenance of CT-P13 in ankylosing spondylitis: 102-week data from the PLANETAS extension study유대현
2017-07Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial유대현
2016-10Efficacy of tocilizumab therapy in Korean patients with adult-onset Still's disease: a multicentre retrospective study of 22 cases유대현
2017-08Efficacy, Safety and Pharmacokinetics of Up to Two Courses of the Rituximab Biosimilar CT-P10 Versus Innovator Rituximab in Patients with Rheumatoid Arthritis: Results up to Week 72 of a Phase I Randomized Controlled Trial유대현
2014-12Etoricoxib in the treatment of Korean patients with osteoarthritis in a double-blind, randomized controlled trial유대현
2017-06Evaluation of the Cross-reactivity of Antidrug Antibodies to CT-P13 and Infliximab Reference Product (Remicade): An Analysis Using Immunoassays Tagged with Both Agents유대현
2015-11Factors Associated with the Use of Complementary and Alternative Medicine for Korean Patients with Rheumatoid Arthritis유대현
2016-12Factors Contributing to Discordance between the 2011 ACR/EULAR Criteria and Physician Clinical Judgment for the Identification of Remission in Patients with Rheumatoid Arthritis유대현

BROWSE